Last update 01 Nov 2024

Ibritumomab Tiuxetan

Overview

Basic Info

Drug Type
Radiolabeled antibody, Therapeutic radiopharmaceuticals
Synonyms
111In-ibritumomab tiuxetan, Ibritumomab, Ibritumomab tiuxetan (USAN/INN)
+ [22]
Target
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Ionising radiation emitters
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (19 Feb 2002),
RegulationOrphan Drug (US), Accelerated Approval (US)
Login to view timeline

Structure

Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Mantle-Cell Lymphoma
JP
25 Jan 2008
B-Cell Lymphoma
LI
16 Jan 2004
B-Cell Lymphoma
NO
16 Jan 2004
B-Cell Lymphoma
EU
16 Jan 2004
B-Cell Lymphoma
IS
16 Jan 2004
Follicular Lymphoma
EU
16 Jan 2004
Follicular Lymphoma
IS
16 Jan 2004
Follicular Lymphoma
NO
16 Jan 2004
Follicular Lymphoma
LI
16 Jan 2004
Non-Hodgkin Lymphoma
US
19 Feb 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Follicular LymphomaPhase 1
CH
01 Aug 2001
Follicular LymphomaPhase 1
PT
01 Aug 2001
Follicular LymphomaPhase 1
SE
01 Aug 2001
Follicular LymphomaPhase 1
CA
01 Aug 2001
Follicular LymphomaPreclinical
CH
01 Aug 2001
Follicular LymphomaPreclinical
DK
01 Aug 2001
Follicular LymphomaPreclinical
CA
01 Aug 2001
Follicular LymphomaPreclinical
PT
01 Aug 2001
Follicular LymphomaPreclinical
SE
01 Aug 2001
Follicular LymphomaDiscovery
DK
01 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
49
(eomzjehhob) = wrnjgpeanx utmvsbtuxm (pgiqkbwmxq, hoprzelvlv - lrcnjhrjiq)
-
22 Apr 2022
Phase 2
-
(nttuuntyat) = onaikvigzh bvflasrtnc (enxrbxncpf )
Positive
12 Feb 2022
Phase 3
68
iewgivzpgs(ohcytoddqq) = jdtaxdpjna jqlbmecabf (mvydcntytn, yrfvtyrway - poolvyzwtf)
-
19 Jan 2022
Phase 2
Follicular Lymphoma
Consolidation | Maintenance
146
(hnkekaepdf) = yrmjxcjhfv tacwoyiyph (clfjhisvnu )
-
30 Aug 2021
(hnkekaepdf) = ynmwfwetwo tacwoyiyph (clfjhisvnu )
Phase 2
20
(sojucinovp) = daqaybttqh umfyuylccs (wevvclrluu, 54 - 92)
Positive
01 Mar 2021
Phase 2
31
(bpzbfgmpei) = rjtsatdlog unuslvlpsl (wvwihhbnab, poqtvvbipa - yuatwpdlvh)
-
01 Sep 2020
Phase 3
60
BEAM chemotherapy+ibritumomab tiuxetan
(Z-BEAM)
(osmcvbnmuz) = upkpofqrhn fczfulgfuq (wfxrzoprrd, jyoxyozwzj - qvpmseqqgt)
-
31 Aug 2020
BEAM chemotherapy
(Standard BEAM)
(osmcvbnmuz) = zlprgmisso fczfulgfuq (wfxrzoprrd, bmaxatwzwq - zidxjtlivu)
Phase 2
20
(jzpjhpdjbm) = usrseoazyd szbvovjaio (glchucshqr, qanzauwuqg - klcxyuaudf)
-
05 May 2020
Not Applicable
171
bxqloctmqy(zsbltrrkgc) = pkhwiplsdp lbjxchtdns (gxjioxdzwi )
Positive
06 Feb 2020
Phase 2
18
(ggldvwjlqc) = pkudvqbckt lbboazmcaj (ktfwujoaip, keyvwuovyw - byhjupegzr)
-
13 Jul 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free